These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28073129)

  • 21. Prolactin Response to Metformin in Cabergoline-Resistant Prolactinomas: A Pilot Study.
    Portari LHC; Correa-Silva SR; Abucham J
    Neuroendocrinology; 2022; 112(1):68-73. PubMed ID: 33477154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy.
    Di Sarno A; Landi ML; Cappabianca P; Di Salle F; Rossi FW; Pivonello R; Di Somma C; Faggiano A; Lombardi G; Colao A
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5256-61. PubMed ID: 11701688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myo-Inositol Potentiates the Inhibitory Effect of Metformin on Prolactin Levels.
    Krysiak R; Basiak M; Szkróbka W; Okopień B
    Pharmacology; 2023; 108(3):238-244. PubMed ID: 36739860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endogenous testosterone determines metformin action on prolactin levels in hyperprolactinaemic men: A pilot study.
    Krysiak R; Szkróbka W; Okopień B
    Basic Clin Pharmacol Toxicol; 2020 Feb; 126(2):110-115. PubMed ID: 31420971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cabergoline: long-acting oral treatment of hyperprolactinemic disorders.
    Ferrari C; Mattei A; Melis GB; Paracchi A; Muratori M; Faglia G; Sghedoni D; Crosignani PG
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1201-6. PubMed ID: 2656736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different Effects of Atorvastatin on Cardiometabolic Risk Factors in Young Women With and Without Hyperprolactinemia.
    Krysiak R; Szkróbka W; Okopień B
    J Clin Pharmacol; 2019 Jan; 59(1):83-89. PubMed ID: 30129670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-lasting prolactin-lowering effect of cabergoline, a new dopamine agonist, in hyperprolactinemic patients.
    Ferrari C; Barbieri C; Caldara R; Mucci M; Codecasa F; Paracchi A; Romano C; Boghen M; Dubini A
    J Clin Endocrinol Metab; 1986 Oct; 63(4):941-5. PubMed ID: 3745407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of hyperprolactinemia and acromegaly with lisuride].
    Berezin M; Elchalal U; Olchovsky D
    Harefuah; 1989 Jun; 116(12):634-7. PubMed ID: 2792946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cabergoline and hyperprolactinaemia: new preparation. Better than bromocriptine.
    Prescrire Int; 2000 Feb; 9(45):195-7. PubMed ID: 11503793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Neutral Effect of Metformin Treatment on Macroprolactin Content in Women with Macroprolactinemia.
    Krysiak R; Szkróbka W; Okopień B
    Exp Clin Endocrinol Diabetes; 2017 Apr; 125(4):223-228. PubMed ID: 27750350
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of bromocriptine treatment on sexual functioning and depressive symptoms in women with mild hyperprolactinemia.
    Krysiak R; Szkróbka W; Okopień B
    Pharmacol Rep; 2018 Apr; 70(2):227-232. PubMed ID: 29475005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: a systematic review of randomized controlled trials and meta-analysis.
    dos Santos Nunes V; El Dib R; Boguszewski CL; Nogueira CR
    Pituitary; 2011 Sep; 14(3):259-65. PubMed ID: 21221817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma calcitonin, IGF-I levels and vertebral bone mineral density in hyperprolactinemic women during bromocriptine treatment.
    Tørring O; Isberg B; Sjöberg HE; Bucht E; Hulting AL
    Acta Endocrinol (Copenh); 1993 May; 128(5):423-7. PubMed ID: 8317189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guidance on the treatment of antipsychotic-induced hyperprolactinemia when switching the antipsychotic is not an option.
    Rusgis MM; Alabbasi AY; Nelson LA
    Am J Health Syst Pharm; 2021 May; 78(10):862-871. PubMed ID: 33954421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of short-term maintenance treatment with cabergoline in microadenoma-related and idiopathic hyperprolactinemia.
    Buyukbayrak EE; Karageyim Karsidag AY; Kars B; Balcik O; Pirimoglu M; Unal O; Turan C
    Arch Gynecol Obstet; 2010 Nov; 282(5):561-6. PubMed ID: 20571820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of cabergoline in the long-term treatment of hyperprolactinemic and acromegalic patients.
    Muratori M; Arosio M; Gambino G; Romano C; Biella O; Faglia G
    J Endocrinol Invest; 1997 Oct; 20(9):537-46. PubMed ID: 9413808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness and tolerability of long term treatment with cabergoline, a new long-lasting ergoline derivative, in hyperprolactinemic patients.
    Ciccarelli E; Giusti M; Miola C; Potenzoni F; Sghedoni D; Camanni F; Giordano G
    J Clin Endocrinol Metab; 1989 Oct; 69(4):725-8. PubMed ID: 2570790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single dose cabergoline versus bromocriptine in inhibition of puerperal lactation: randomised, double blind, multicentre study. European Multicentre Study Group for Cabergoline in Lactation Inhibition.
    BMJ; 1991 Jun; 302(6789):1367-71. PubMed ID: 1676318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of vaginal bromocriptine in treating women with hyperprolactinemia.
    Kletzky OA; Vermesh M
    Fertil Steril; 1989 Feb; 51(2):269-72. PubMed ID: 2912773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Metformin on Hypothalamic-Pituitary-Thyroid Axis Activity in Elderly Antipsychotic-Treated Women With Type 2 Diabetes and Subclinical Hypothyroidism: A Preliminary Study.
    Krysiak R; Szkróbka W; Okopień B
    J Clin Pharmacol; 2018 May; 58(5):586-592. PubMed ID: 29251783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.